NIH-funded research R01 grant

Understanding how specific cells in the colon respond to inflammation

Official title: Activation of deep crypt secretory cells in colonic inflammation

Funded at Children's Hospital of Los Angeles · NIH-10945113 · Data updated 2026-11-12

This study is looking at special cells in the colon that help keep your gut healthy, to see how they react to inflammation and if they can help heal the colon during conditions like inflammatory bowel disease (IBD), with the hope of finding new treatments that could improve your health.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionChildren's Hospital of Los Angeles
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startSeptember 15, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$551,112
NIH project number1R01DK140323-01
Project IDNIH-10945113 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from inflammatory bowel disease or other colonic inflammatory conditions.

Less likely to help

Patients with non-inflammatory gastrointestinal disorders may not receive any benefit from this research.

What this research studies

This research investigates deep crypt secretory (DCS) cells, which are specialized cells in the colon that play a role in maintaining gut health. The study aims to understand how these cells respond to inflammation and whether their activation can help in healing the colon during inflammatory bowel disease (IBD). By examining the mechanisms that regulate these cells, the research seeks to identify potential therapeutic targets for improving colonic health. Patients may benefit from insights that could lead to new treatments for conditions like IBD.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that enhance the healing of the colon in patients with inflammatory bowel disease.

How similar studies have gone: Other research has shown promise in targeting specific cell populations for therapeutic purposes, suggesting that this approach could be effective.

Where this research is happening

  • Children's Hospital of Los Angeles
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Schumacher, Michael Andrew — Children's Hospital of Los Angeles
  • Study coordinator: Schumacher, Michael Andrew

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.